Literature DB >> 6849538

Sleep apnea and nocturnal hypoventilation after western equine encephalitis.

D P White, F Miller, R W Erickson.   

Abstract

That viral encephalitis can produce daytime hypoventilation is well appreciated, but an association of this infection with the development of a prolonged disturbance of breathing during sleep once the ventilatory disorder during wakefulness has resolved, has not been reported. We describe a young male who required assisted mechanical ventilation in association with western equine encephalitis. Normal waking ventilation returned over 3 to 4 wk, but frequent apneas and severe hypoventilation persisted during sleep with a near absence of waking ventilatory response to chemical stimuli. Over 3 months there was considerable improvement in breathing during sleep associated with an increase in both hypoxic and hypercapnic ventilatory responsiveness.

Entities:  

Mesh:

Year:  1983        PMID: 6849538     DOI: 10.1164/arrd.1983.127.1.132

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Obstructive sleep apnoea associated with syringomyelia.

Authors:  C Ellis; N Curzen; H Katifi
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

2.  Central Alveolar Hypoventilation Syndromes.

Authors:  Hiren Muzumdar; Raanan Arens
Journal:  Sleep Med Clin       Date:  2008-12-01

Review 3.  Mechanisms and management of central sleep apnea.

Authors:  P J Hanly
Journal:  Lung       Date:  1992       Impact factor: 2.584

4.  Mouse Model of Neurological Complications Resulting from Encephalitic Alphavirus Infection.

Authors:  Shannon E Ronca; Jeanon Smith; Takaaki Koma; Magda M Miller; Nadezhda Yun; Kelly T Dineley; Slobodan Paessler
Journal:  Front Microbiol       Date:  2017-02-07       Impact factor: 5.640

Review 5.  Neurological Sequelae Resulting from Encephalitic Alphavirus Infection.

Authors:  Shannon E Ronca; Kelly T Dineley; Slobodan Paessler
Journal:  Front Microbiol       Date:  2016-06-20       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.